Lab Whole Genome Testing
ID: HT941024Q2104Type: Combined Synopsis/Solicitation
Overview

Buyer

DEPT OF DEFENSEDEFENSE HEALTH AGENCY (DHA)DEFENSE HEALTH AGENCYFALLS CHURCH, VA, 22042, USA

NAICS

Medical Laboratories (621511)

PSC

MEDICAL- LABORATORY TESTING (Q301)

Original Source

https://sam.gov/opp/5afca116fe95411ab4f2b2f0a9c77d65/view
Timeline
    Description

    The Department of Defense, through the Defense Health Agency, is seeking qualified contractors to provide whole genome sequencing testing services for the Naval Medical Center San Diego. The procurement involves a non-personal services contract that spans a base year from October 1, 2024, to September 30, 2025, with four optional renewal years, focusing on delivering high-quality genomic testing while ensuring compliance with industry standards such as HIPAA and CAP accreditation. This initiative is crucial for enhancing health services for military personnel, leveraging advanced genomic testing capabilities to improve diagnosis and treatment. Interested vendors must submit their quotes by September 20, 2024, and can direct inquiries to Jojie Urrete at jojie.n.urrete.civ@health.mil.

    Point(s) of Contact
    Jojie Urrete
    jojie.n.urrete.civ@health.mil
    Files
    Title
    Posted
    2. HT941024Q2104 Past Performance Questionnaire.docx
    The Past Performance Questionnaire (PPQ) is a key assessment tool utilized by the Defense Health Agency's Western Markets Contracting Division to evaluate the past performance of an Offeror being considered for a U.S. Government contract. The document outlines the required information regarding the Offeror, including project details, evaluator information, and a structured rating system ranging from "Exceptional" to "Unacceptable." Evaluators are prompted to provide ratings on various aspects of the Offeror’s performance, such as management of subcontractors, quality of work, compliance with safety standards, and the ability to meet performance schedules. Additionally, it inquires about any issues such as cure notices and whether the customer was satisfied with the end product. The responses will inform the government’s decision-making process by providing insights into the Offeror’s past performance, integrity, and overall capability to fulfill contract requirements effectively. The purpose of the PPQ reflects a commitment to ensure government contracts are awarded based on reliable performance history, ensuring quality and accountability in government procurement.
    DHA PWS Non-Personal Services-updated 09 13 24.pdf
    The document outlines a Performance Work Statement (PWS) for a non-personal services contract to provide whole genome sequencing testing for the Department of Defense (DoD), specifically supporting the Naval Medical Center San Diego. The contractor is responsible for delivering all necessary services, materials, and compliance with industry standards, including HIPAA regulations and CAP accreditation. Key tasks include providing whole genome sequencing tests with specific turnaround times and quality assurance measures, ensuring reliable communication of results via fax, and maintaining all government data securely within U.S. territories unless otherwise permitted. The contract has a performance period spanning from October 1, 2024, to September 30, 2029, comprising one base year and four optional years. Additionally, contractor personnel must comply with security protocols, including obtaining appropriate cybersecurity certifications, reporting incident management protocols, and adhering to strict data handling requirements as defined by DoD regulations. The document emphasizes rigorous quality control measures and performance monitoring to satisfy the expected standards of care in genomic testing. This PWS reflects the government's commitment to enhancing health and treatment services for military personnel through advanced genomic testing capabilities.
    Lifecycle
    Title
    Type
    Lab Whole Genome Testing
    Currently viewing
    Combined Synopsis/Solicitation
    Similar Opportunities
    Genomics Sequencing Services for the NIAID Centralized Sequencing Program
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), is seeking quotations for genomics sequencing services to support its Centralized Sequencing Program (CSP). The procurement aims to acquire comprehensive clinical whole genome sequencing services, including interpretation and reporting, to enhance the understanding of infectious diseases and improve patient care, with a focus on delivering results within a four-week turnaround time. This initiative is critical for advancing clinical research and understanding the genetic basis of diseases, as the NIAID conducts numerous clinical trials annually. Interested vendors must submit their quotes by September 23, 2024, and direct any inquiries to Seth Schaffer at seth.schaffer@nih.gov or Linda Smith at linda.smith2@nih.gov.
    Reference Laboratory Testing Services
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency (DHA), intends to award a sole source contract for Reference Laboratory Testing Services to Diagnostic Laboratory Services, Inc. This contract will support the Laboratory Department at Naval Hospital Guam by providing comprehensive diagnostic testing and specialized laboratory services, including blood tests, genetic testing, and microbiology, which are critical for ensuring timely and accurate patient diagnoses. The contract is set to begin on September 19, 2024, with options for extension through September 30, 2026, and interested vendors must submit capability statements by 1:00 PM Pacific Daylight Time on September 12, 2024, to Merlinda Labaco at merlinda.m.labaco.civ@health.mil for consideration.
    Q301--Oncotype DX GPS Testing
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is conducting market research to identify potential contractors for Oncotype DX GPS testing and related prostate cancer diagnostic services at the VA Northern California Healthcare System. The selected contractor will be responsible for providing gene expression assays, including ConfirmMDx, SelectMDx, and Oncotype DS GPS testing, along with all necessary personnel, equipment, and specimen transportation kits, while ensuring compliance with accreditation and regulatory standards. This testing is crucial for optimizing prostate cancer treatment and prognosis, thereby enhancing patient care and potentially reducing healthcare costs. Interested vendors must submit their capabilities and relevant information by September 23, 2024, to Contracting Officer Krystal Zoufaly at krystal.zoufaly@va.gov, with the Sources Sought number 36C26124Q1064 in the subject line.
    Medical Lab Technician and Medical Lab Technologists
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency (DHA), is seeking to negotiate a sole-source contract with Distinctive Health Spectrum Care JV LLC for the provision of medical laboratory personnel at the Naval Hospital Guam. The procurement aims to add two Medical Lab Technologists and one Medical Lab Technician under contract HT001418D0029, Task Order N6264521F0140, for the period from October 1, 2024, to June 27, 2025, reflecting the critical need for laboratory testing services in a military healthcare setting. Interested parties may submit capability statements for consideration, although the government may opt not to pursue competitive proposals based on the responses received, with a deadline for challenges set for September 26, 2024. For further inquiries, interested vendors can contact Uyen Tran at uyen.t.tran6.civ@health.mil.
    Microbiology Supplies and Reagents at U.S. Naval Hospital Guam
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency (DHA), is seeking qualified small businesses to provide microbiology supplies and reagents for the U.S. Naval Hospital in Guam. The procurement includes essential quality controls and reagents necessary for laboratory testing operations, with a delivery period from October 1, 2024, to September 30, 2025, and options for four additional years. This acquisition is critical for maintaining public health and ensuring reliable access to diagnostic tools within the military healthcare system. Interested contractors must submit their quotes electronically by 9:00 AM PDT on September 19, 2024, and can direct inquiries to Nicole Ventinilla at nicole.e.ventinilla.civ@health.mil.
    AUTOPSY PATHOLOGIST NAVAL MEDICAL CENTER DAN DIEGO
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency, is seeking qualified small businesses to provide autopsy pathologist services at the Naval Medical Center San Diego (NMCSD). The procurement involves non-personal services for one Autopsy Pathologist, responsible for handling hospital, fetal, and forensic autopsy cases, as well as managing administrative and quality assurance duties from September 30, 2024, to September 29, 2029. These services are critical for maintaining the laboratory's operational integrity and compliance with medical standards. Interested parties must submit their quotes electronically by 10:00 AM PDT on September 20, 2024, and can contact Jane Pamintuan at jane.v.pamintuan.civ@health.mil for further information.
    Quantum SI Platinum Instrument
    Active
    Dept Of Defense
    The Department of Defense, through the Naval Health Research Center (NHRC), is seeking quotes for the procurement of a Quantum SI Platinum Instrument and associated items, under a total small business set-aside contract. The procurement includes a Quantum SI Platinum Instrument, an Advanced Next-Generation Protein Sequencing Training session, and various sequencing and library preparation kits, all intended for laboratory use in San Diego, California. These items are critical for ongoing studies and must be delivered promptly, with specific delivery schedules outlined for the kits. Interested vendors must register with the System for Award Management (SAM) and provide detailed quotes by referencing solicitation number N63116-25-Q-0501. For further inquiries, vendors can contact David L. Hill at (619) 767-4901 or via email at david.l.hill4.civ@health.mil.
    Laboratory Diagnostic Services
    Active
    Dept Of Defense
    The Department of Defense, specifically the Massachusetts Army National Guard (MA ARNG), is seeking qualified vendors to provide laboratory diagnostic services for its personnel from September 30, 2024, to September 29, 2025. The contractor will be responsible for delivering comprehensive blood and urine laboratory services, including staffing, equipment, and adherence to strict quality control measures, ensuring timely collection, transportation, and testing of samples. These services are crucial for maintaining the health readiness of soldiers, as they must meet specific medical requirements for duty. Interested small businesses must submit their quotes via email by the specified deadline, and further inquiries can be directed to Lacy Phongsaly at lacy.r.phongsaly.civ@army.mil or Lars Bernard at jeffrey.l.bernard6.civ@army.mil. The solicitation number for this opportunity is W912SV-24-Q-0024.
    Lab Radiological Sample Analysis Contract
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency (DHA), is soliciting proposals for a Lab Radiological Sample Analysis Contract to support the Defense Centers for Public Health - Aberdeen (DCPH-A). This contract involves the non-personal services requirement for the analysis of radiological samples across various parameters, which is crucial for enhancing public health readiness and ensuring the quality of the Public Health Enterprise. The solicitation is prepared in accordance with Federal Acquisition Regulation (FAR) guidelines, and interested vendors are required to submit quotes as no written solicitation will be issued. For further details, interested parties can contact Kenneth Grenier at kenneth.e.grenier2.civ@health.mil or by phone at 301-619-2728, with the archive date for submissions set for October 4, 2024.
    Next-Generation Sequencing (NGS) Liquid Handling Systems – Brand Name or Equal
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking quotes for two Next-Generation Sequencing (NGS) Liquid Handling Systems to enhance research capabilities at its Bethesda, Maryland campus. These systems are essential for high-throughput processing in infectious disease research, particularly for single cell-based antibody discovery and RNA/DNA processing, which are critical for pandemic preparedness. Interested vendors must submit their quotes by 12:00 pm EST on September 26, 2024, including detailed specifications and compliance with federal regulations, to Daveta H. Brown at daveta.brown@nih.gov.